WBP2 and breast carcinoma: Lim and colleagues found that silencing of AIP4 blocks ubiquitin-dependent proteasomal degradation of the YAP/TAZ transcriptional coactivator WBP2 as well as promotes anchorage-independent colony and in vivo tumor growth in breast cancer (Lim et al., 2016).